January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

January 15, 2025

Hydrophobic, Chlorhexidine, vs. Standard PICCs

A randomized trial compares hydrophobic, chlorhexidine, and standard polyurethane peripherally inserted central catheters.

Conexiant

January 15, 2025

CMR-PCWP Correlates with Heart Failure Biomarkers

In HFrEF patients, cardiovascular magnetic resonance-estimated pulmonary capillary wedge pressure "correlates with clinical and ultrasound markers of congestion," demonstrates potential as a non-invasive alternative to traditional pressure measurements.

Conexiant

January 06, 2025

Muscle Loss Progression Signals Heart Disease Risk

A new study reveals significant associations between changes in sarcopenia status and cardiovascular disease risk, shedding light on the clinical characteristics and comorbidity prevalence in different groups.

Conexiant

January 03, 2025

Surgeon General Issues Advisory on Alcohol, Cancer Link

Of all breast cancer cases in the U.S., 16.4% are directly linked to alcohol consumption.

Conexiant

January 03, 2025

Does CVD Correlate with Advanced Breast Cancer?

Case-control study evaluates the association between cardiovascular disease and breast cancer stage at diagnosis, revealing potential links in specific subtypes.

Conexiant

December 30, 2024

Light Wine Consumption May Cut CVD Risk in Half

"It is critical to note that the study’s findings reinforce the notion that these cardiovascular benefits are limited to moderate wine consumption."

Conexiant

December 27, 2024

More Aerobic Minutes Equals More Weight Loss

At 150 minutes per week, participants averaged a weight loss of 2.79 kg, while at 300 minutes per week, weight loss increased to 4.19 kg.

Conexiant

October 19, 2023

Current State of M-TEER and T-TEER

Dr. David Adler discusses transcatheter mitral therapies updates and enrolling trials.

Sentara